Objective: To review and provide details about the primary and secondary findings from the Multimodal Treatment study of ADHD (MTA) published during the past decade as three sets of articles. Method: In the second of a two part article, we provide additional background and detail required by the complexity of the MTA to address confusion and controversy about the findings outlined in part I (the Executive Summary). Results: We present details about the gold standard used to produce scientific evidence, the randomized clinical trial (RCT), which we applied to evaluate the long-term effects of two well-established unimodal treatments, Medication Management (MedMGT) and behavior therapy (Beh), the multimodal combination (Comb), and treatment “as usual” in the community (CC). For each of the first three assessment points defined by RCT methods and included in intent-to-treat analyses, we discuss our definition of evidence from the MTA, interpretation of the serial presentations of findings at each assessment point with a different definition of long-term varying from weeks to years, and qualification of the interim conclusions about long-term effects of treatments for ADHD based on many exploratory analyses described in additional published articles. Conclusions: Using a question and answer format, we discuss the possible clinical relevance of the MTA and present some practical suggestions based on current knowledge and uncertainties facing families, clinicians, and investigators regarding the long-term use of stimulant medication and behavioral therapy in the treatment of children with ADHD. (J. of Att. Dis. 2008; 12(1) 15-43)
Abikoff, M., Hechtman, L., Klein, R.G., Weiss, G., Fleiss, K., Etcovitch, J., et al. (2004). Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment . Journal of the American Academy of Child and Adolescent Psychiatry, 43, 802-811.
2.
Arnold, L.E., Abikoff, H.B., Cantwell, D.P., Conners, C.K., Elliott, G., Greenhill, L.L., et al. (1997a). National Institute of Mental Health collaborative multimodal treatment study of children with ADHD (MTA): Design challenges and choices. Archives of General Psychiatry, 54, 865-870.
3.
Arnold, L.E., Abikoff, H.B., Cantwell, D.P., Conners, C.K., Elliott, G., Greenhill, L.L., et al. (1997b). National Institute of Mental Health collaborative multimodal treatment study of children with ADHD (MTA): Design, methodology, and protocol evolution. Journal of Attention Disorders, 2(3), 141-150.
4.
Arnold, L.E., Chuang, S., Davies, M., Kraemer, H.C., Abikoff, H.B., Conners, C.K., et al. (2004). Nine months of multicomponent behavioral treatment for ADHD and effectiveness of MTA fading procedures. Journal of Abnormal Child Psychology, 32(1), 39-51.
5.
Arnold, L.E., Elliott, M., Sachs, L., Bird, H., Kraemer, H.C., Wells, K.C., et al. (2003). Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD. Journal of Consulting and Clinical Psychology, 71, 713-727.
6.
Barkley, R.A. (2000). Commentary on the multimodal treatment study of children with ADHD. Journal of Abnormal Child Psychology, 28, 595-599.
7.
Biederman, J., Wilens, T., Mick, E., Spencer, T.J., & Faraone, S.V. (1999). Pharmacotherapy of attention-deficit/hyperactivity reduces risk of substance use disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 29, 546-557.
8.
Boyle, M.H., Jadad, A.R., & Allnut, D.R. (1999). Lesson from large trials: The MTA study as a model for evaluating the treatment of childhood psychiatric disorder. Canadian Journal of Psychiatry, 44, 991-998.
9.
Breggin, P.R. (2001). MTA study has flaws. Archives of General Psychiatry, 58, 1184.
10.
Conners, C.K., Epstein, J.N., March, J.S., Angold, A., Wells, K.C., Klaric, J., et al. (2001). Multimodal treatment of ADHD in the MTA: An alternative outcome analysis. Journal of the American Academy of Child and Adolescent Psychiatry, 40(2), 159-167.
11.
Cunningham, C.E. (1999). In the wake of the MTA: Charting a new course for the study and treatment of children with attention-deficit hyperactivity disorder. Canadian Journal of Psychiatry, 44, 999-1006.
12.
DeVeaugh-Geiss, J., March, J., Shapiro, M., Andreason, P.J., Emslie, G., Ford, L.M., et al. (2006). Child and adolescent psychopharmacology in the new millennium: A workshop for academia, industry, and government. Journal of American Academic Child Adolescent Psychiatry, 45, 261-270.
13.
Dopfner, M., Breuer, D., Schurmann, S., Metternich, T.W., Rademacher, C., & Lehmkuhl, G. (2004). Effectiveness of an adaptive multimodal treatment in children with attention-deficit/ hyperactivity disorder-global outcome . European Child Adolescent Psychiatry, 13, 117-129.
14.
Gibbons, R.D., Hedeker, D., Elkin, I., Waternaux, C., Kraemer, H.C., Greenhous, J.B., Shea, M.T., Imber, S.D., Sotsky, S.M., Watkins, J.T.Some conceptual and statistical issues in analysis of longitudinal psychiatric data: Applications to the NIMH treatment of depression collaboration research program dataset. Archives of General Psychiatry, 50, 739-750.
15.
Greene, R.W., & Ablon, J.S. (2001). What does the MTA study tell us about the effective psychosocial treatment for ADHD? Journal of Clinical Child Adolescent Psychology, 30, 114-121.
16.
Greenhill, L.L., Abikoff, H.B., Arnold, L.E., Cantwell, D.P., Conners, C.K., Elliott, G., et al. (1996). Medication treatment strategies in the MTA study: Relevance to clinicians and researchers. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1304-1313.
17.
Greenhill, L.L., Swanson, J.M., Vitiello, B., Davies, M., Clevenger, W., Wu, M., et al. (2001). Impairment and deportment responses to different methylphenidate doses in children with ADHD: The MTA titration. Journal of the American Academy of Child and Adolescent Psychiatry40, 180-187.
18.
Hechtman, L., Etcovitch, J., Platt, R., Arnold, L.E., Abikoff, H.B., Newcorn, J.H., et al. (2005). Does multimodal treatment of ADHD decrease other diagnoses? Clinical Neuroscience Research, 5(5-6), 273-282.
19.
Hedeker, D., & Gibbons, R.D. (2006). Longitudinal data analysis. New York: John Wiley & Sons.
20.
Hinshaw, S.P. (2007). Moderators and mediators of treatment outcome for youth with ADHD: Understanding for whom and how interventions work. Journal of Pediatric Psychology, Advanced Access.
21.
Hinshaw, S.P., March, J., Abikoff, H.B., Arnold, L.E., Cantwell, D.P., Conners, C.K., et al. (1997). Comprehensive assessment of childhood attention-deficit hyperactivity disorder in the context of a multisite, multimodal clinical trial. Journal of Attention Deficit Disorders, 1, 217-234.
22.
Hinshaw, S.P., Owens, E.B., Wells, K.C., Kraemer, H.C., Abikoff, H.B., Arnold, L.E., et al. (2000). Family processes and treatment outcome in the MTA: Negative/ineffective parenting practices in relation to multimodal treatment. Journal of Abnormal Child Psychology, 28(6), 555-568.
23.
Hoagwood, K., Jensen, P., Arnold, L.E., Roper, M., Severe, J., Odbert, C., et al. (2004). Reliability of the services for children and adolescents parent interview (SCAPI). Journal of the American Academy of Child & Adolescent Psychiatry, 43(11), 1345-1354.
24.
Jensen, P.S. (2001). ADHD comorbidity and treatment outcomes in the MTA. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 134-136.
25.
Jensen, P.S. (1999). Facts vs. fancies concerning the multimodal treatment study of attention deficit hyperactivity disorder (MTA). Canadian Journal of Psychiatry, 44, 975-980.
26.
Jensen, P.S., Arnold, L.E., Swanson, J., Vitiello, B., Abikoff, H.B., Greenhill, L.L., et al. (2007). Follow-up of the NIMH MTA study at 36 months after randomization. Journal of the American Academy of Child and Adolescent Psychiatry, 46(8), 988-1001.
27.
Jensen, P.S., Hinshaw, S.P., Kraemer, H.C., Lenora, N., Newcorn, J.H., Abikoff, H.B., et al. (2001). ADHD comorbidity findings from the MTA study: Comparing comorbid subgroups. Journal of the American Academy of Child and Adolescent Psychiatry, 40(2), 147-158.
28.
Jensen, P.S., Hinshaw, S.P., Swanson, J.M., Greenhill, L.L., Conners, C.K., Arnold, L.E., et al. (2001). Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and applications for primary care providers . Developmental Behavior Pediatrics, 22, 60-73.
29.
Jensen, P.S., Hoagwood, K., & Trickett, E.J. (1999). Ivory towers or earthen trenches? Community collaborations to foster real-world research. Applied Developmental Science, 3, 206-212.
30.
Klein, R.G. (2001). MTA findings fail to consider methodological flaws . Archives of General Psychiatry, 58, 1184-1185.
31.
Kraemer H.C., Yesavage, J.A., Taylor, J.L., & Kupfer, D. (2000). How can we learn about developmental processes from cross-sectional studies, or can we? American Journal of Psychiatry, 157(2): 163-171.
32.
Kraemer H.C., & Robinson, T.N. (2005). Are certain multicenter randomized clinical trial structures misleading clinical and policy decisions ? Contemporary Clinical Trials, 26: 518-529.
33.
Kraemer, H.C., Wilson, T.G., Fairburn, C.G., & Agras, W.S. (2002). Mediators and moderators of treatment effects in randomized clinical trials. Archives of General Psychiatry , 59, 877-883.
34.
Marcus, S.M., & Gibbons, R.D. (2001). Estimating the efficacy of receiving treatment in randomized clinical trials with noncompliance. Health Services and Outcomes Research Methodology, 2, 247-258.
35.
Molina, B.S.G., Flory, K., Hinshaw, S.P., Greiner, A.R., Arnold, E., Swanson, J., et al. (2007). Delinquent behavior and emerging substance use in the MTA at 36-months: Prevalence, course, and treatment effects. Journal of the American Academy of Child and Adolescent Psychiatry , 46(8), 1027-1039.
36.
MTA Cooperative Group. (2004a). National Institute of Mental Health multimodal treatment study of ADHD follow-up: Changes in effectiveness and growth after the end of treatment. Pediatrics, 113(4), 762-769.
37.
MTA Cooperative Group. (1999a). 14-month randomized clinical trial of treatment strategies for attention deficit hyperactivity disorder. Archives of General Psychiatry, 56, 1073-1086.
38.
MTA Cooperative Group. (1999b). Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: The multimodal treatment study of children with attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56, 1088-1096.
39.
MTA Cooperative Group. (2004b). National Institute of Mental Health multimodal treatment study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder (ADHD). Pediatrics, 113(4), 754-761.
40.
MTA Research Symposium. (2007). Investigators' opinions of important findings. Washington DC: CHADD.
41.
National Institute of Health. (1998, November 16-18). Diagnosis and treatment of attention deficit hyperactivity disorder. Retrieved from http://consensus.nih.gov/1998/1998AttentionDeficitHyperactivityDisorder110htmlhtm
42.
National Institute of Health. (2005, November 14-15). Program on clinical research policy analysis and coordination considering usual medical care in clinical trial design: Scientific and ethical issues. Bethesda, MD: Author.
43.
Owens, E.B., Hinshaw, S.P., Kraemer, H.C., Arnold, L.E., Abikoff, H.B., Cantwell, D.P., et al. (2003). Which treatment for whom for ADHD? Moderators of treatment response in the MTA. Journal of Consulting and Clinical Psychology, 71(3), 540-552.
44.
Pelham, W.E. (1999). The NIMH multimodal treatment study for ADHD: Just say yes to drugs alone? Canadian Journal of Psychiatry , 44(10), 981-990.
45.
Pelham, W.E., Gnagy, E.M., Greiner, A.R., Hoza, B., Hinshaw, S.P., Swanson, J.M., et al. (2000). Behavioral vs. behavioral and pharmacological treatment in ADHD children attending a summer treatment program. Journal of Abnormal Child Psychology, 28(6), 507-526.
46.
Richters, J.E., Arnold, L.E., Jensen, P.S., Abikoff, H., Conners, C.K., Greenhill, L.L., et al. (1995). NIMH collaborative multisite multimodal treatment study of children with ADHD: I: Background and rationale. Journal of the American Academy of Child and Adolescent Psychiatry , 34, 987-1000.
47.
Roche, A.F., Lipman, R.S., Overall, J.E., & Hung, W. (1979). The effects of stimulants medication of the growth of hyperkinetic children. Pediatrics, 63, 847-850.
48.
Safer, D.J., Allen, R.P., & Barr, E. (1975). Growth rebound after termination of stimulant drugs. Journal of Pediatrics, 86, 113-116.
49.
Santosh, P.J., Taylor, E., Swanson, J., Wigal, T., Chuang, S., Davies, M., et al. (2005). Reanalysis of the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) based on ICD-10 criteria for hyperkinetic disorder (HD). Clinical Neuroscience Research , 5(5-6).
50.
Spencer T., Biederman J., Harding M., O'Donnell D., Faraone SV, Wilens TE (1996), Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?J. Am. Acad. Child Adolesc. Psychiatry35, 1460-1469.
51.
Swanson, J.M. (2005, November 14-15). Case presentation: Case study #2: Multimodal treatment study of ADHD (MTA): Considering usual medical care in clinical trial design. NIH Program on Research Policy Analysis and Coordination, Bethesda, MD.
52.
Swanson, J.M., Arnold, L.E., Vitiello, B., Abikoff, H.B., Wells, K.C., Pelham, W.E., et al. (2002). Response to commentary on the multimodal treatment of study of ADHD (MTA): Mining the meaning of the MTA. Journal of Abnormal Child Psychology, 30, 327-332.
53.
Swanson, J.M., Elliott, G.R., Greenhill, L.L., Wigal, T., Arnold, L.E., Vitiello, B., et al. (2007). Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. Journal of the American Academy of Child and Adolescent Psychiatry, 46(8), 1014-1026.
54.
Swanson, J.M., Hinshaw, S.P., Arnold, L.E., Gibbons, R., Marcus, S., Hur, K., et al. (2007). Secondary evaluations of MTA 36-month outcomes: Propensity score and growth mixture model analyses. Journal of the American Academy of Child and Adolescent Psychiatry, 46(8), 1002-1013.
55.
Swanson, J.M., Kraemer, H.C., Hinshaw, S.P., Arnold, L.E., Conners, C.K., Abikoff, H.B., et al. (2001). Clinical relevance of the primary findings of the MTA: Success rates based on severity of ADHD and ODD symptoms at the end of treatment. Journal of the American Academy of Child and Adolescent Psychiatry, 40(2), 168-179.
56.
Taylor, E. (1999). Development of clinical services for attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56, 1097-1099.
57.
van der Oord, S., Prins, P.J., Oosterlaan, J., & Emmerkamp, P.M. (2007). Does brief, clinically based, intensive multimodal behavioral therapy enhance the effects of methylphenidate in children with ADHD?European Child Adolescent Psychiatry,16, 48-57.
58.
Vitiello, B., Severe, J.B., Greenhill, L.L., Arnold, L.E., Abikoff, H.B., Bukstein, O., et al. (2001). Methylphenidate dosage for children with ADHD over time under controlled conditions: Lessons from the MTA. Journal of the American Academy of Psychiatry, 40, 188-196.
59.
Wells, K.C. (2001). Comprehensive versus matched psychosocial treatment in the MTA study: Conceptual and empirical issues. Journal of Clinical Child Psychology, 30, 131-135.
60.
Wells, K.C., Chi, T.C., Hinshaw, S.P., Epstein, J.N., Pfiffner, L.J., Nebel-Schwain, M., et al. (2006). Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with ADHD. Journal of Consulting and Clinical Psychology, 74, 649-657.
61.
Wells, K.C., Epstein, J., Hinshaw, S., Conners, C.K., Abikoff, H.B., Abramowitz, A., et al. (2000). Parenting and family stress treatment outcomes in attention deficit hyperactivity disorder (ADHD): An empirical analysis in the MTA study. Journal of Abnormal Child Psychology, 28(6), 543-554.
62.
Wells, K.C., Pelham, W.E., Kotkin, R.A., Hoza, B., Abikoff, H.B., Abramowitz, A., et al. (2000). Psychosocial treatment strategies in the MTA study: Rationale, methods, and critical issues in design and implementation . Journal of Abnormal Child Psychology, 28(6), 483-506.
63.
Wilens TE, Faraone SV, Biederman J., Gunawardene S.: Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics2003; 111:179-185.
